| pubmed-article:21231906 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:21231906 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:21231906 | lifeskim:mentions | umls-concept:C0229671 | lld:lifeskim |
| pubmed-article:21231906 | lifeskim:mentions | umls-concept:C2239176 | lld:lifeskim |
| pubmed-article:21231906 | lifeskim:mentions | umls-concept:C0019189 | lld:lifeskim |
| pubmed-article:21231906 | lifeskim:mentions | umls-concept:C0018042 | lld:lifeskim |
| pubmed-article:21231906 | lifeskim:mentions | umls-concept:C1623038 | lld:lifeskim |
| pubmed-article:21231906 | lifeskim:mentions | umls-concept:C0019067 | lld:lifeskim |
| pubmed-article:21231906 | lifeskim:mentions | umls-concept:C0220825 | lld:lifeskim |
| pubmed-article:21231906 | lifeskim:mentions | umls-concept:C0950248 | lld:lifeskim |
| pubmed-article:21231906 | lifeskim:mentions | umls-concept:C0015961 | lld:lifeskim |
| pubmed-article:21231906 | pubmed:issue | 4 | lld:pubmed |
| pubmed-article:21231906 | pubmed:dateCreated | 2011-4-12 | lld:pubmed |
| pubmed-article:21231906 | pubmed:abstractText | Golgi protein-73 (GP73) and fucosylated proteins have been proposed as potential serum markers for liver disease and/or hepatocellular carcinoma (HCC). The purpose of this study was to compare the sensitivity and specificity of serum GP73 and fucosylated hemopexin (Fuc-HPX) with ?-fetoprotein (AFP) and with protein induced by the absence of vitamin K or antagonist-II (PIVKA-II) for diagnosing chronic hepatitis, cirrhosis, and HCC. | lld:pubmed |
| pubmed-article:21231906 | pubmed:language | eng | lld:pubmed |
| pubmed-article:21231906 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21231906 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:21231906 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21231906 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21231906 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21231906 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21231906 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21231906 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21231906 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21231906 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21231906 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:21231906 | pubmed:month | Apr | lld:pubmed |
| pubmed-article:21231906 | pubmed:issn | 1434-6621 | lld:pubmed |
| pubmed-article:21231906 | pubmed:author | pubmed-author:ChanDaniel... | lld:pubmed |
| pubmed-article:21231906 | pubmed:author | pubmed-author:SokollLori... | lld:pubmed |
| pubmed-article:21231906 | pubmed:author | pubmed-author:NakagawaMasat... | lld:pubmed |
| pubmed-article:21231906 | pubmed:author | pubmed-author:ElliottDebraD | lld:pubmed |
| pubmed-article:21231906 | pubmed:author | pubmed-author:DowellBarry... | lld:pubmed |
| pubmed-article:21231906 | pubmed:author | pubmed-author:MorotaKaoriK | lld:pubmed |
| pubmed-article:21231906 | pubmed:author | pubmed-author:HemkenPhilip... | lld:pubmed |
| pubmed-article:21231906 | pubmed:author | pubmed-author:SekiyaRikaR | lld:pubmed |
| pubmed-article:21231906 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:21231906 | pubmed:volume | 49 | lld:pubmed |
| pubmed-article:21231906 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:21231906 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:21231906 | pubmed:pagination | 711-8 | lld:pubmed |
| pubmed-article:21231906 | pubmed:dateRevised | 2011-11-17 | lld:pubmed |
| pubmed-article:21231906 | pubmed:meshHeading | pubmed-meshheading:21231906... | lld:pubmed |
| pubmed-article:21231906 | pubmed:meshHeading | pubmed-meshheading:21231906... | lld:pubmed |
| pubmed-article:21231906 | pubmed:meshHeading | pubmed-meshheading:21231906... | lld:pubmed |
| pubmed-article:21231906 | pubmed:meshHeading | pubmed-meshheading:21231906... | lld:pubmed |
| pubmed-article:21231906 | pubmed:meshHeading | pubmed-meshheading:21231906... | lld:pubmed |
| pubmed-article:21231906 | pubmed:meshHeading | pubmed-meshheading:21231906... | lld:pubmed |
| pubmed-article:21231906 | pubmed:meshHeading | pubmed-meshheading:21231906... | lld:pubmed |
| pubmed-article:21231906 | pubmed:meshHeading | pubmed-meshheading:21231906... | lld:pubmed |
| pubmed-article:21231906 | pubmed:meshHeading | pubmed-meshheading:21231906... | lld:pubmed |
| pubmed-article:21231906 | pubmed:meshHeading | pubmed-meshheading:21231906... | lld:pubmed |
| pubmed-article:21231906 | pubmed:meshHeading | pubmed-meshheading:21231906... | lld:pubmed |
| pubmed-article:21231906 | pubmed:meshHeading | pubmed-meshheading:21231906... | lld:pubmed |
| pubmed-article:21231906 | pubmed:meshHeading | pubmed-meshheading:21231906... | lld:pubmed |
| pubmed-article:21231906 | pubmed:meshHeading | pubmed-meshheading:21231906... | lld:pubmed |
| pubmed-article:21231906 | pubmed:meshHeading | pubmed-meshheading:21231906... | lld:pubmed |
| pubmed-article:21231906 | pubmed:meshHeading | pubmed-meshheading:21231906... | lld:pubmed |
| pubmed-article:21231906 | pubmed:meshHeading | pubmed-meshheading:21231906... | lld:pubmed |
| pubmed-article:21231906 | pubmed:year | 2011 | lld:pubmed |
| pubmed-article:21231906 | pubmed:articleTitle | A comparative evaluation of Golgi protein-73, fucosylated hemopexin, ?-fetoprotein, and PIVKA-II in the serum of patients with chronic hepatitis, cirrhosis, and hepatocellular carcinoma. | lld:pubmed |
| pubmed-article:21231906 | pubmed:affiliation | Research and Development, Abbott Japan Co., Ltd., Matsudo, Chiba, Japan. kaori.morota@abbott.com | lld:pubmed |
| pubmed-article:21231906 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:21231906 | pubmed:publicationType | Comparative Study | lld:pubmed |
